Molecular diversity of Proteus mirabilis isolates producing extended-spectrum β-lactamases in a French university hospital

被引:20
作者
Biendo, M
Thomas, D
Laurans, G
Hamdad-Daoudi, F
Canarelli, B
Rousseau, F
Castelain, S
Eb, F
机构
[1] CHU Nord, Lab Bacteriol & Hyg, F-80054 Amiens, France
[2] Grp Hosp Sud, Virol Lab, Amiens, France
关键词
beta-lactamases; ESBLs; PFGE; Proteus mirabilis; resistance; TEM-type ESBLs;
D O I
10.1111/j.1469-0691.2005.01147.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Between February 1997 and December 2002, 3340 hospitalised patients yielded samples positive for Proteus mirabilis, of whom 45 (1.3%) were colonised/infected by P. mirabilis producing extended-spectrum beta-lactamases (ESBLs). The gross incidence of patients colonised/infected by ESBL-producing P. mirabilis was 1.61/10(5) days of hospitalisation, with 20% of isolates being collected from patients in urology wards, most frequently (53.3%) from urine samples. Seventeen (37.7%) of the 43 isolates were obtained from samples collected within 48 h of hospitalisation, indicating that they were community-acquired. Isoelectric focusing assays and sequencing identified the TEM-24, TEM-92 and TEM-52 ESBLs. Pulsed-field gel electrophoresis revealed eight pulsotypes (I-VIII), with the two most common pulsotypes, IV and VI, comprising ten (23.3%) and 12 (26.6%) isolates, respectively. These pulsotypes were considered to represent epidemic strains and spread in various wards of the hospital.
引用
收藏
页码:395 / 401
页数:7
相关论文
共 33 条
[1]   Extended-spectrum β-lactamase-producing Enterobacteriaceae in community and private health care centers [J].
Arpin, C ;
Dubois, V ;
Coulange, L ;
André, C ;
Fischer, I ;
Noury, P ;
Grobost, F ;
Brochet, JP ;
Jullin, J ;
Dutilh, B ;
Larribet, G ;
Lagrange, I ;
Quentin, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) :3506-3514
[2]   Regional dissemination of Salmonella enterica serovar Enteritidis is season dependent [J].
Biendo, M ;
Laurans, G ;
Thomas, D ;
Dechepy, O ;
Hamdad-Daoudi, F ;
Canarelli, B ;
Eb, F .
CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (05) :360-369
[3]   Diversity of TEM mutants in Proteus mirabilis [J].
Bonnet, R ;
De Champs, C ;
Sirot, D ;
Chanal, C ;
Labia, R ;
Sirot, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2671-2677
[4]  
Borer Abraham, 2002, Med Sci Monit, V8, pCR44
[5]   Most Enterobacter aerogenes strains in France belong to a prevalent clone [J].
Bosi, C ;
Davin-Regli, A ;
Bornet, C ;
Mallea, M ;
Pages, JM ;
Bollet, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (07) :2165-2169
[6]  
BRUNBUISSON C, 1990, LETT INFECT, V5, P373
[7]  
BUTREAULEMAIRE M, 1998, INFECT NOSOCOMIALES, P119
[8]   Prevalence of β-lactamases among 1,072 clinical strains of Proteus mirabilis:: a 2-year survey in a French hospital [J].
Chanal, C ;
Bonnet, R ;
De Champs, C ;
Sirot, D ;
Labia, R ;
Sirot, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1930-1935
[9]   Survey of prevalence of extended spectrum beta-lactamases among Enterobacteriaceae [J].
Chanal, C ;
Sirot, D ;
Romaszko, JP ;
Bret, L ;
Sirot, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) :127-132
[10]   Extended-spectrum beta-lactamase-producing bacteria: an epidemiological study in the Strasbourg university hospital. [J].
Claudon, A ;
Meunier, O ;
Arpin, C ;
Quentin, C ;
Christmann, D ;
Koffel, JC ;
Jehl, F .
MEDECINE ET MALADIES INFECTIEUSES, 2002, 32 (05) :228-240